Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.65 -0.05 (-7.76%)
At close: Oct 23, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Cash & Current Investments (2018 - 2026)

Updated

Milestone Pharmaceuticals (MIST) recorded Cash & Current Investments of $170.6 million in Q2 2026, up 293.1% from $43.4 million a year earlier but down 7.4% from the prior quarter.

Analysis

Milestone Pharmaceuticals (MIST) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Milestone Pharmaceuticals reported Cash & Current Investments of $106 million, up 52.1% from FY2024.

  • Annual Cash & Current Investments has increased for three straight years, though with a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $69.7 million in FY2024 (+5.6%), $66 million in FY2023 (+2.3%), $64.5 million in FY2022 (-43.5%) and $114.1 million in FY2021 (-19.8%).
  • Quarterly Cash & Current Investments has ranged from $43.4 million in Q2 2025 to $184.2 million in Q1 2026 over the past five years.
  • On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 62.9% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 293.1% in Q2 2026, against a decline of 47.9% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $184.2 million (Q1 2026), $106 million (Q4 2025) and $82.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Milestone Pharmaceuticals 89.86 Mn -80.74 Mn - 170.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 170.60 Mn
Mar 31, 2026 184.20 Mn
Dec 31, 2025 106.00 Mn
Sep 30, 2025 82.60 Mn
Jun 30, 2025 43.40 Mn
Mar 31, 2025 56.00 Mn
Dec 31, 2024 69.70 Mn
Sep 30, 2024 76.40 Mn
Jun 30, 2024 83.30 Mn
Mar 31, 2024 89.50 Mn
Dec 31, 2023 66.00 Mn
Sep 30, 2023 75.70 Mn
Jun 30, 2023 87.60 Mn
Mar 31, 2023 101.00 Mn
Dec 31, 2022 64.50 Mn
Sep 30, 2022 77.20 Mn
Jun 30, 2022 86.20 Mn
Mar 31, 2022 100.20 Mn
Dec 31, 2021 114.10 Mn
Sep 30, 2021 126.40 Mn
API Access

Milestone Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MIST&period=max&api_key=YOUR_API_KEY